SRI-31255
SRI-31255 is an orally active LRRK2 inhibitor, with IC50 values of 520 nM for human wild-type (WT) and 427 nM for the G2019S mutant. It inhibits kinase activity by binding to the ATP-binding pocket of LRRK2, providing neuroprotective effects. SRI-31255 serves as a lead compound for developing LRRK2-targeted therapies for Parkinson’s disease research.
Product Specifications
CAS Number
905580-86-1
Field of Research
Cell Biology
Smiles
N ([C@@H]1C=2C (CC1) =CC=CC2) C3=C4C (NC=C4) =NC=N3
Molecular Formula
C15H14N4
Molecular Weight
250.30
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP3-11578F 0.1 mL
Mouse Monoclonal CD84/SLAMF5 Antibody (153-4D9) [FITC]
Sign In for Pricing
View Details 
sc-332162 1 g
1- (2-Chloro-phenyl) -3-mercapto-5,6,7,8-tetrahydro-isoquinoline-4-carbonitrile
Sign In for Pricing
View Details RC217977L4 10 µg
BAF53A (ACTL6A) (NM_004301) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 